Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMRN Immuron Ltd

交易中 08-11 14:39:58 EDT

1.12

+0.02

+1.81%

最高1.12	最低1.09	成交量7,170
今开1.11	昨收1.10	日振幅2.51%
总市值903.89万	流通市值884.11万	总股本807.12万
成交额7,958	换手率0.09%	流通股本789.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMRN","market":"US","secType":"STK","nameCN":"Immuron Ltd","latestPrice":1.1199,"timestamp":1786473340188,"preClose":1.1,"halted":0,"volume":7170,"delay":0,"changeRate":0.018090909090908915,"floatShares":7894500,"shares":8071200,"eps":-0.488634,"marketStatus":"交易中","change":0.0199,"latestTime":"08-11 14:39:58 EDT","open":1.11,"high":1.12,"low":1.0924,"amount":7957.980132000001,"amplitude":0.025091,"askPrice":1.16,"askSize":15,"bidPrice":1.1,"bidSize":118,"shortable":3,"etf":0,"ttmEps":-0.488634,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1786478400000},"marketStatusCode":2,"adr":1,"adrRate":40,"exchange":"NASDAQ","adjPreClose":1.1,"preHourTrading":{"tag":"盘前","latestPrice":1.084,"preClose":1.1,"latestTime":"08:46 EDT","volume":49,"amount":55.1980002,"timestamp":1786452369480,"change":-0.016,"changeRate":-0.014545,"amplitude":0.054545},"postHourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.1,"latestTime":"18:44 EDT","volume":1466,"amount":1670.5778,"timestamp":1786401878954,"change":0.04,"changeRate":0.036364,"amplitude":0.036364},"volumeRatio":0.71456},"requestUrl":"/m/hq/s/IMRN","defaultTab":"news","newsList":[{"id":"2614015687","title":"Immuron Limited盘中异动 早盘股价大涨11.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614015687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2614015687?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:34","pubTimestamp":1772030065,"startTime":"0","endTime":"0","summary":"北京时间2026年02月25日22时34分，Immuron Limited股票出现波动，股价大幅上涨11.77%。截至发稿，该股报0.810美元/股，成交量1966股，换手率0.02%，振幅4.73%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.04%。Immuron Limited公司简介：Immuron Ltd 是一家商业化和临床阶段的生物制药公司，拥有专有技术平台，专注于多克隆抗体，以解决尚未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223425a71e8e78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225223425a71e8e78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611911981","title":"Immuron Limited盘中异动 股价大涨8.05%报0.760美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611911981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2611911981?lang=zh_cn&edition=full","pubTime":"2026-02-13 23:02","pubTimestamp":1770994923,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日23时02分，Immuron Limited股票出现波动，股价快速拉升8.05%。截至发稿，该股报0.760美元/股，成交量5151股，换手率0.06%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.47%。Immuron Limited公司简介：Immuron Ltd 是一家商业化和临床阶段的生物制药公司，拥有专有技术平台，专注于多克隆抗体，以解决尚未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213230203a4a1478f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213230203a4a1478f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609546737","title":"Immuron Limited盘中异动 急速拉升7.56%报0.839美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609546737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2609546737?lang=zh_cn&edition=full","pubTime":"2026-02-06 22:35","pubTimestamp":1770388502,"startTime":"0","endTime":"0","summary":"北京时间2026年02月06日22时35分，Immuron Limited股票出现异动，股价快速拉升7.56%。截至发稿，该股报0.839美元/股，成交量1971股，换手率0.02%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.85%。Immuron Limited公司简介：Immuron Ltd 是一家商业化和临床阶段的生物制药公司，拥有专有技术平台，专注于多克隆抗体，以解决尚未满足的医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223502a6dc0c88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206223502a6dc0c88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222374","title":"Immuron Limited盘中异动 急速上涨12.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518222374?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613497,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Immuron Limited股票出现波动，股价大幅上涨12.99%。截至发稿，该股报1.99美元/股，成交量416股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.59%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213137a26a247f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213137a26a247f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517941563","title":"Immuron Limited盘中异动 早盘快速上涨13.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517941563?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:17","pubTimestamp":1741191475,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时17分，Immuron Limited股票出现异动，股价快速拉升13.32%。截至发稿，该股报1.99美元/股，成交量159股，换手率0.00%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.22%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001756989d5ed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306001756989d5ed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516658650","title":"Immuron Limited盘中异动 快速下挫5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516658650","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516658650?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:38","pubTimestamp":1741030707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时38分，Immuron Limited股票出现波动，股价快速下跌5.26%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.61%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033827a25d950f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304033827a25d950f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514492370","title":"Immuron Limited盘中异动 股价大涨6.65%报1.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514492370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514492370?lang=zh_cn&edition=full","pubTime":"2025-02-26 04:50","pubTimestamp":1740516642,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日04时50分，Immuron Limited股票出现波动，股价大幅上涨6.65%。截至发稿，该股报1.98美元/股，成交量786股，换手率0.01%，振幅3.50%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.13%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045042abdcd48c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226045042abdcd48c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513299102","title":"Immuron Limited盘中异动 早盘股价大涨7.60%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299102","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513299102?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:08","pubTimestamp":1740150481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时08分，Immuron Limited股票出现波动，股价急速上涨7.60%。截至发稿，该股报2.03美元/股，成交量509股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.06%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230801abd7b804&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221230801abd7b804&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509375922","title":"Immuron Limited盘中异动 大幅跳水5.32%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509375922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509375922?lang=zh_cn&edition=full","pubTime":"2025-02-06 02:18","pubTimestamp":1738779481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时18分，Immuron Limited股票出现异动，股价急速跳水5.32%。截至发稿，该股报1.99美元/股，成交量359股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为2.10%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206021801a23aab67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206021801a23aab67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","KTTA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508463749","title":"Immuron Limited盘中异动 股价大涨5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508463749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508463749?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:25","pubTimestamp":1738682737,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时25分，Immuron Limited股票出现异动，股价大幅上涨5.67%。截至发稿，该股报2.09美元/股，成交量353股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.80%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204232537abc23341&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204232537abc23341&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508129292","title":"Immuron Limited盘中异动 快速拉升5.29%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508129292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508129292?lang=zh_cn&edition=full","pubTime":"2025-02-04 02:10","pubTimestamp":1738606202,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日02时10分，Immuron Limited股票出现波动，股价大幅上涨5.29%。截至发稿，该股报2.15美元/股，成交量3368股，换手率0.06%，振幅4.90%。Immuron Limited股票所在的生物技术行业中，整体跌幅为0.61%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204021002abc1334c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204021002abc1334c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507049961","title":"Immuron Limited盘中异动 大幅跳水5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507049961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507049961?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:39","pubTimestamp":1738337949,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时39分，Immuron Limited股票出现波动，股价急速下挫5.56%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.15%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233910abbe4825&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233910abbe4825&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507672477","title":"Immuron Limited盘中异动 下午盘快速上涨8.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672477","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507672477?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:36","pubTimestamp":1738265788,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时36分，Immuron Limited股票出现异动，股价快速上涨8.26%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.22%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131033629abbd7fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131033629abbd7fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506551439","title":"Immuron Limited股价上涨12.82% 市值涨160.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506551439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506551439?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:30","pubTimestamp":1738074646,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时30分，Immuron Limited股票出现异动，股价快速拉升12.82%。截至发稿，该股报2.20美元/股，成交量5250股，换手率0.09%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.00%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223046abbb6556&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223046abbb6556&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506130144","title":"Immuron Limited盘中异动 早盘股价大涨7.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506130144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506130144?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:57","pubTimestamp":1737993430,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时57分，Immuron Limited股票出现波动，股价大幅拉升7.25%。截至发稿，该股报2.15美元/股，成交量1144股，换手率0.02%，振幅1.20%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.80%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235710961246ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127235710961246ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505046637","title":"Immuron Limited盘中异动 急速上涨6.48%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505046637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505046637?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:49","pubTimestamp":1737650992,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时49分，Immuron Limited股票出现异动，股价快速上涨6.48%。截至发稿，该股报2.30美元/股，成交量564股，换手率0.01%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.52%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240049539870d4db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240049539870d4db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505519721","title":"Immuron Limited盘中异动 早盘急速跳水8.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505519721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505519721?lang=zh_cn&edition=full","pubTime":"2025-01-22 22:57","pubTimestamp":1737557862,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时57分，Immuron Limited股票出现波动，股价大幅下挫8.08%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.40%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225743960d0382&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122225743960d0382&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505723002","title":"Immuron Limited盘中异动 股价大跌7.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505723002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505723002?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:02","pubTimestamp":1737471731,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时02分，Immuron Limited股票出现异动，股价大幅下跌7.80%。截至发稿，该股报1.98美元/股，成交量6681股，换手率0.12%，振幅6.05%。Immuron Limited股票所在的生物技术行业中，整体涨幅为1.08%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230211abb34e67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230211abb34e67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504608161","title":"Immuron Limited盘中异动 早盘股价大涨13.64%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504608161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504608161?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:30","pubTimestamp":1737124242,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时30分，Immuron Limited股票出现异动，股价快速上涨13.64%。截至发稿，该股报2.25美元/股，成交量1.0438万股，换手率0.18%，振幅0.00%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.00%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223043986a1486&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223043986a1486&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503397640","title":"Immuron Limited盘中异动 早盘股价大跌7.44%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503397640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503397640?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:35","pubTimestamp":1736951708,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时35分，Immuron Limited股票出现波动，股价急速下跌7.44%。截至发稿，该股报1.85美元/股，成交量2040股，换手率0.04%，振幅7.44%。Immuron Limited股票所在的生物技术行业中，整体涨幅为0.81%。Immuron Limited公司简介：Immuron Ltd 是一家商业和临床阶段的生物制药公司，专注于开发和商业化一类新型免疫调节剂多克隆抗体，用于治疗肝病、传染病和其他免疫介导疾病，如结肠炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223508ababf3a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223508ababf3a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immuron.com","stockEarnings":[{"period":"1week","weight":0.0377},{"period":"1month","weight":-0.1057},{"period":"3month","weight":0.3733},{"period":"6month","weight":0.5152},{"period":"1year","weight":-0.3567},{"period":"ytd","weight":0.4426}],"compareEarnings":[{"period":"1week","weight":0.0203},{"period":"1month","weight":0.0239},{"period":"3month","weight":0.0472},{"period":"6month","weight":0.1172},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1336}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Immuron Limited于1994年根据澳大利亚法律成立。该公司是一家商业和临床阶段的生物制药公司，拥有一个专利技术平台，专注于开发和商业化一类新型的特异性靶向多克隆抗体，公司相信这种抗体能够解决严重的未满足医疗需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.777778,"avgChangeRate":0.23094},{"month":2,"riseRate":0.111111,"avgChangeRate":-0.086676},{"month":3,"riseRate":0.444444,"avgChangeRate":0.021723},{"month":4,"riseRate":0.444444,"avgChangeRate":0.009553},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.004211},{"month":6,"riseRate":0.375,"avgChangeRate":0.252686},{"month":7,"riseRate":0.555556,"avgChangeRate":0.020715},{"month":8,"riseRate":0.666667,"avgChangeRate":0.000843},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.058783},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.085183},{"month":11,"riseRate":0.444444,"avgChangeRate":0.02204},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.14399}],"exchange":"NASDAQ","name":"Immuron Ltd","nameEN":"Immuron Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Immuron Ltd,IMRN,Immuron Ltd股票,Immuron Ltd股票老虎,Immuron Ltd股票老虎国际,Immuron Ltd行情,Immuron Ltd股票行情,Immuron Ltd股价,Immuron Ltd股市,Immuron Ltd股票价格,Immuron Ltd股票交易,Immuron Ltd股票购买,Immuron Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Immuron Ltd(IMRN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Immuron Ltd(IMRN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}